Early homing behavior of Stro-1- mesenchyme-like cells derived from human embryonic stem cells in an immunocompetent xenogeneic animal model

Biochemical and Biophysical Research Communications

Volumn 394, Issue 3, 2010, Pages 616-622

  Su, Zhongyuan ^a   Wu, Rongrong ^a   Tan, Zhou ^a   Li, Ying ^b   Chen, Liangbiao ^c   Luo, Jingfeng ^a   Zhang, Ming ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

^c INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY   (China)

Author keywords

Acute liver injury; CXCR4; Hepatic differentiation; Homing; Human embryonic stem cells; Mesenchymal stem cells

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ALPHA FETOPROTEIN; CD14 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CELL PROTEIN; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR6; CHEMOKINE RECEPTOR CXCR7; ENDOGLIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PROTEIN STRO 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL HOMING; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; IN VITRO STUDY; LIVER INJURY; LIVER REGENERATION; MESENCHYME CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALPHA-FETOPROTEINS; AMIDES; ANIMALS; ANTIGENS, SURFACE; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL SEPARATION; EMBRYONIC STEM CELLS; HUMANS; IMMUNOCOMPETENCE; LIVER; LIVER REGENERATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED ICR; PYRIDINES; RECEPTORS, CHEMOKINE; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 77950627240     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.03.033     Document Type: Article

References (28)

1. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., Deans R., Keating A., Prockop D., and Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8 (2006) 315-317
2. Snykers S., De Kock J., Rogiers V., and Vanhaecke T. In vitro differentiation of embryonic and adult stem cells into hepatocytes: state of the art. Stem Cells 27 (2009) 577-605
3. Chang Y.J., Liu J.W., Lin P.C., Sun L.Y., Peng C.W., Luo G.H., Chen T.M., Lee R.P., Lin S.Z., Harn H.J., and Chiou T.W. Mesenchymal stem cells facilitate recovery from chemically induced liver damage and decrease liver fibrosis. Life Sci. (2009)
4. Tsai P.C., Fu T.W., Chen Y.M., Ko T.L., Chen T.H., Shih Y.H., Hung S.C., and Fu Y.S. The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis. Liver Transpl. 15 (2009) 484-495
5. Jung K.H., Shin H.P., Lee S., Lim Y.J., Hwang S.H., Han H., Park H.K., Chung J.H., and Yim S.V. Effect of human umbilical cord blood-derived mesenchymal stem cells in a cirrhotic rat model. Liver Int. 29 (2009) 898-909
6. Hardjo M., Miyazaki M., Sakaguchi M., Masaka T., Ibrahim S., Kataoka K., and Huh N.H. Suppression of carbon tetrachloride-induced liver fibrosis by transplantation of a clonal mesenchymal stem cell line derived from rat bone marrow. Cell Transplant. 18 (2009) 89-99
7. Fehrer C., and Lepperdinger G. Mesenchymal stem cell aging. Exp. Gerontol. 40 (2005) 926-930
8. Stolzing A., and Scutt A. Age-related impairment of mesenchymal progenitor cell function. Aging Cell 5 (2006) 213-224
9. Hwang N.S., Varghese S., Lee H.J., Zhang Z., Ye Z., Bae J., Cheng L., and Elisseeff J. In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells. Proc. Natl. Acad. Sci. USA 105 (2008) 20641-20646
10. Chen X., Song X.H., Yin Z., Zou X.H., Wang L.L., Hu H., Cao T., Zheng M., and Ouyang H.W. Stepwise differentiation of human embryonic stem cells promotes tendon regeneration by secreting fetal tendon matrix and differentiation factors. Stem Cells 27 (2009) 1276-1287
11. Kyriakou C., Rabin N., Pizzey A., Nathwani A., and Yong K. Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model. Haematologica 93 (2008) 1457-1465
12. + human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment. Blood 103 (2004) 3313-3319
13. Wynn R.F., Hart C.A., Corradi-Perini C., O'Neill L., Evans C.A., Wraith J.E., Fairbairn L.J., and Bellantuono I. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 104 (2004) 2643-2645
14. Cheng Z., Ou L., Zhou X., Li F., Jia X., Zhang Y., Liu X., Li Y., Ward C.A., Melo L.G., and Kong D. Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol. Ther. 16 (2008) 571-579
15. Khurana S., and Mukhopadhyay A. Characterization of the potential subpopulation of bone marrow cells involved in the repair of injured liver tissue. Stem Cells 25 (2007) 1439-1447
16. Ponte A.L., Marais E., Gallay N., Langonne A., Delorme B., Herault O., Charbord P., and Domenech J. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 25 (2007) 1737-1745
17. Chamulitrat W., Blazka M.E., Jordan S.J., Luster M.I., and Mason R.P. Tumor necrosis factor-alpha and nitric oxide production in endotoxin-primed rats administered carbon tetrachloride. Life Sci. 57 (1995) 2273-2280
18. Sackstein R., Merzaban J.S., Cain D.W., Dagia N.M., Spencer J.A., Lin C.P., and Wohlgemuth R. Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat. Med. 14 (2008) 181-187
19. Kraitchman D.L., Tatsumi M., Gilson W.D., Ishimori T., Kedziorek D., Walczak P., Segars W.P., Chen H.H., Fritzges D., Izbudak I., Young R.G., Marcelino M., Pittenger M.F., Solaiyappan M., Boston R.C., Tsui B.M., Wahl R.L., and Bulte J.W. Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation 112 (2005) 1451-1461
20. Barbash I.M., Chouraqui P., Baron J., Feinberg M.S., Etzion S., Tessone A., Miller L., Guetta E., Zipori D., Kedes L.H., Kloner R.A., and Leor J. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 108 (2003) 863-868
21. di Bonzo L.V., Ferrero I., Cravanzola C., Mareschi K., Rustichell D., Novo E., Sanavio F., Cannito S., Zamara E., Bertero M., Davit A., Francica S., Novelli F., Colombatto S., Fagioli F., and Parola M. Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential. Gut 57 (2008) 223-231
22. Yen B.L., Chang C.J., Liu K.J., Chen Y.C., Hu H.I., Bai C.H., and Yen M.L. Brief report - human embryonic stem cell-derived mesenchymal progenitors possess strong immunosuppressive effects toward natural killer cells as well as T lymphocytes. Stem Cells 27 (2009) 451-456
23. Mishra P.K. Bone marrow-derived mesenchymal stem cells for treatment of heart failure: is it all paracrine actions and immunomodulation. J. Cardiovasc. Med. (Hagerstown) 9 (2008) 122-128
24. Wang X.J., and Li Q.P. The roles of mesenchymal stem cells (MSCs) therapy in ischemic heart diseases. Biochem. Biophys. Res. Commun. 359 (2007) 189-193
25. Iwamoto S., Mihara K., Downing J.R., Pui C.H., and Campana D. Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase. J. Clin. Invest. 117 (2007) 1049-1057
26. Horwitz E.M., and Prather W.R. Cytokines as the major mechanism of mesenchymal stem cell clinical activity: expanding the spectrum of cell therapy. Isr. Med. Assoc. J. 11 (2009) 209-211
27. Brenner S., Whiting-Theobald N., Kawai T., Linton G.F., Rudikoff A.G., Choi U., Ryser M.F., Murphy P.M., Sechler J.M., and Malech H.L. CXCR4-transgene expression significantly improves marrow engraftment of cultured hematopoietic stem cells. Stem Cells 22 (2004) 1128-1133
28. Karp J.M., and Leng Teo G.S. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell 4 (2009) 206-216